#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15624	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2141	723.5	0	.	n	.	0	C451T	SNP	451	451	C	713	713	T	867	T,C	420,390	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15624	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2141	723.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1446	1446	C	897	C	828	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28488	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3543	799.0	0	.	n	.	0	T695C	SNP	695	695	T	972	972	C	816	C,T,A	751,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28488	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3543	799.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2248	2248	C	948	C,T,A	854,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28488	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3543	799.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2322	2322	A	894	A	842	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28488	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3543	799.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2874	2874	C	882	C,T	825,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2388	folP	855	855	100.0	folP.l6.c30.ctg.1	1605	148.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1063	1065	AGC	255;253;250	A;G;C	239;237;233	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6772	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3407	197.7	1	SNP	p	S91F	1	.	.	271	273	TTC	637	639	TTC	220;221;219	T;T;C,T	207;210;206,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6772	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3407	197.7	1	SNP	p	D95G	1	.	.	283	285	GGC	649	651	GGC	213;214;218	G;G;C	197;201;202	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6772	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3407	197.7	1	SNP	p	G95N	0	.	.	283	285	GGC	649	651	GGC	213;214;218	G;G;C	197;201;202	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1906	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1171	159.8	0	.	p	.	0	A39T	NONSYN	115	117	GCC	448	450	ACC	221;218;218	A,G,C;C;C	197,1,2;208;211	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1906	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1171	159.8	0	.	p	.	0	R44H	NONSYN	130	132	CGC	463	465	CAC	218;220;223	C;A,G,C;C	208;201,1,1;211	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1906	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1171	159.8	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	646	648	CAC	227;229;226	C;A,C;C	213;212,1;211	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1906	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1171	159.8	1	SNP	p	G45D	0	.	.	133	135	GGC	466	468	GGC	223;222;222	G;G;C	209;209;207	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1010	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1027	97.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5864	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	194.6	1	SNP	p	D86N	0	.	.	256	258	GAC	535	537	GAC	255;258;260	G;A;C	235;231;240	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5864	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	194.6	1	SNP	p	R87W	0	.	.	259	261	CGT	538	540	CGT	260;259;260	C,G;G;T	240,1;231;234	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5864	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	194.6	1	SNP	p	S87R	1	.	.	259	261	CGT	538	540	CGT	260;259;260	C,G;G;T	240,1;231;234	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5864	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	194.6	1	SNP	p	R87I	0	.	.	259	261	CGT	538	540	CGT	260;259;260	C,G;G;T	240,1;231;234	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5864	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	194.6	1	SNP	p	S88P	0	.	.	262	264	TCC	541	543	TCC	260;258;258	T;C;C	235;239;240	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4922	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2805	174.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1626	1628	GGC	232;228;227	G;G;C	217;211;207	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4780	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2666	178.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1378	1380	GCC	273;276;275	G;C;C,T	249;250;250,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4780	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2666	178.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1381	1383	ATG	277;275;277	A;T;G	253;250;253	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4780	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2666	178.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1393	1395	ACC	267;269;267	A;C;C	244;249;247	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4780	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2666	178.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1393	1395	ACC	267;269;267	A;C;C	244;249;247	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4780	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2666	178.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1894	1896	ACC	235;230;229	A;C;C	212;214;212	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4780	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2666	178.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1948	1950	GCG	228;227;226	G;C;G	212;211;209	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4780	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2666	178.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1948	1950	GCG	228;227;226	G;C;G	212;211;209	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4780	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2666	178.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2071	2073	GGT	210;203;203	G;G;T	195;190;181	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4780	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2666	178.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2080	2082	AGC	194;193;194	A;G;C,T	179;182;178,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4780	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2666	178.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2098	2100	CCG	173;179;183	C,G;C,G;G	129,4;135,1;136	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6752	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3287	204.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1706	1708	CCG	267;266;262	C,T;C;G	232,1;243;237	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2440	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1630	147.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	492	492	C	188	C,T	169,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	285	91.0	porB1a.l15.c17.ctg.2	483	29.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	223	225	AAT	24;24;25	A;A;T	24;23;24	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	285	91.0	porB1a.l15.c17.ctg.2	483	29.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	226	228	AAT	25;24;25	A;A;T	25;23;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	285	91.0	porB1a.l15.c17.ctg.2	483	29.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	250	252	GCA	28;28;29	G;C;A	28;28;28	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	285	91.0	porB1a.l15.c17.ctg.2	483	29.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	273	275	GTA	25;25;26	G;T;A	25;25;26	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	285	91.0	porB1a.l15.c17.ctg.2	483	29.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	282	282	A	25	A	25	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3320	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1410	230.7	0	.	p	.	0	G48E	NONSYN	142	144	GGA	377	379	GAA	259;258;261	G;A;A	242;238;240	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3320	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1410	230.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	863	865	AGA	303;301;300	A,G;G,A;A	280,1;275,1;277	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3320	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1410	230.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	884	886	GGT	310;310;307	G,A,C;G;T	283,1,1;287;279	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3320	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1410	230.7	1	SNP	p	G120K	1	.	.	358	360	AAG	593	595	AAG	286;285;286	A;A;G	261;261;256	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3320	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1410	230.7	1	SNP	p	A121N	1	.	.	361	363	AAC	596	598	AAC	286;286;283	A;A;C,A	257;256;257,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3320	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1410	230.7	1	SNP	p	N121D	0	.	.	361	363	AAC	596	598	AAC	286;286;283	A;A;C,A	257;256;257,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12022	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4979	240.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1302	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1129	114.6	1	SNP	p	V57M	1	.	.	169	171	ATG	554	556	ATG	251;250;251	A;T;G	243;242;243	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
